norethindrone acetate has been researched along with Low Bone Density in 2 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buserelin-treated rats developed similarly depressed plasma oestradiol-17 beta values in the presence and absence of progestogen, and both groups given buserelin had significantly smaller uteri than controls or rats given norethindrone without buserelin." | 1.29 | Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia. ( Gold, E; Goulding, A, 1993) |
| " One month after ovariectomy, the rats were dosed once daily for 6 months with either a low dose of growth hormone (GH) (0." | 1.29 | Growth hormone normalizes vertebral strength in ovariectomized rats. ( Andreassen, TT; Eschen, C, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goulding, A | 1 |
| Gold, E | 1 |
| Eschen, C | 1 |
| Andreassen, TT | 1 |
2 other studies available for norethindrone acetate and Low Bone Density
| Article | Year |
|---|---|
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Buserelin; Calcium; Disease Models, Animal; Estradio | 1993 |
Growth hormone normalizes vertebral strength in ovariectomized rats.
Topics: Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Disease Models, Animal; Estradiol; Fem | 1995 |